The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- phenox Inc.
- Study ID
- NCT07143019
- Status
- Recruiting
Conditions
- Aneurysm, Intracranial
- Brain Aneurysm
- Fusiform Aneurysm
- Hemorrhagic Stroke
- Saccular Aneurysm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Flow diversion — DEVICEThe p48 MW HPC and p64 MW HPC Flow Modulation Device is indicated for use in the treatment of intracranial aneurysms (IAs) arising from a parent vessel with a diameter of ≥2.0mm and ≤5.0 mm.
Study Details
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.
Key Dates
- Start date
- Mar 16, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2032
Study Design
- Enrollment
- 214 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention/TreatmentDevice: Flow diversion using the p48 MW HPC Device: Flow diversion using the p64 MW HPC
Primary Outcome Measure
Primary Efficacy and Performance Endpoint: Number of subjects with 100% occlusion of the target aneurysm without significant parent artery stenosis and no retreatment of the target aneurysm from the index procedure to the 12-month follow-up visit. [ Time Frame: 12 months ]
Central Contacts
- Mairéad Cleary+353 91 740 100
- Nguyet T Labenski
Locations (17)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | Andrew Ducruet, MD (PRINCIPAL_INVESTIGATOR) |
| University of Colorado Anschutz | Aurora | Colorado | 80045 | Joshua Seinfeld, MD (PRINCIPAL_INVESTIGATOR) |
| Swedish Medical Research Center | Englewood | Colorado | 80113 | Don Frei, MD (PRINCIPAL_INVESTIGATOR) |
| Baptist Health Research Institute | Jacksonville | Florida | 32207 | Eric Sauvageau, MD (PRINCIPAL_INVESTIGATOR) |
| Piedmont Atlanta Hospital | Atlanta | Georgia | 30309 | Michael F Stiefel, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Advocate Lutheran General Hospital | Park Ridge | Illinois | 60068 | Krishna Joshi, MD (PRINCIPAL_INVESTIGATOR) |
| University of Iowa | Iowa City | Iowa | 52242 | Julia Ivey Daniel F Waldschmidt Kathleen Dlouhy, MD, MBA, MA (PRINCIPAL_INVESTIGATOR) |
| Tufts Medical Center | Boston | Massachusetts | 02111 | Adel Malek, MD (PRINCIPAL_INVESTIGATOR) |
| UBNS | Buffalo | New York | 14203 | Michaela Laskowski Ellen Carl Adnan Siddiqui, MD, PhD, FAHA (PRINCIPAL_INVESTIGATOR) |
| North Shore University Hospital - Northwell Health | Manhasset | New York | 11030 | Athos Patsalides, MD (PRINCIPAL_INVESTIGATOR) |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | Dawn Madigan, RN, BSN,CCRC David Fiorella, MD (PRINCIPAL_INVESTIGATOR) |
| East Carolina University Health Medical Center | Greenville | North Carolina | 27834 | Richard T Dalyai, MD (PRINCIPAL_INVESTIGATOR) |
| The University of Oklahoma | Oklahoma City | Oklahoma | 73104 | Michael Omini Hakeem Shakir, MD (PRINCIPAL_INVESTIGATOR) |
| Oregon Health & Science University Hospital (OHSU) / Oregon Stroke Center | Portland | Oregon | 97239 | Emma Blackburn Ryan A Priest, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Jan-Karl Burkhardt, MD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Rohan Chitale, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington - Harborview Medical Center | Seattle | Washington | 98104 | Michael Levitt, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Hospital Implementation of a Stroke Protocol for Emergency Evaluation and DispositionRecruiting · University of Chicago · New Haven, Connecticut
- Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)Recruiting · Stryker Neurovascular · Tucson, Arizona
- Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke PatientsRecruiting · EMVision Medical Devices Ltd · Jacksonville, Florida
- Left Atrial Strain and Cryptogenic StrokeRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania